The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response
Open accessAbstract
INTRODUCTION: Mild cognitive impairment following chemotherapy is one of the most commonly reported post treatment symptoms by breast cancer survivors. This deterioration in cognitive function, commonly referred to as "chemobrain" or "chemofog," was largely unacknowledged by the medical community until recent years. Although chemobrain has now become the subject of more vigorous exploration, little is known about this specific phenomenon's psychosocial impact on breast cancer survivors. This research documents in-depth the effects that cognitive impairment has on women's personal and professional lives, and our data suggest that greater attention needs to be focused on this arena of survivorship. METHODS: The results are based on an in-depth qualitative study of 74 white and African American breast cancer survivors in California who experience post-treatment side effects. The data reported herein were obtained through the use of focus groups and in-depth interviews. RESULTS: Our data indicate that cognitive impairment can be problematic for survivors, with many asserting that it is their most troublesome post treatment symptom. Survivors report diminished quality of life and daily functioning as a result of chemobrain. Respondents detail a range of coping strategies that they are forced to employ in order to manage their social and professional lives. DISCUSSIONS/CONCLUSIONS: Chemobrain significantly impairs a proportion of cancer survivors, at great cost to them economically, emotionally, and interpersonally. This suggests that more research needs to be conducted on the psychosocial ramifications of post treatment symptoms in order to inform the efforts of the medical and mental health communities as well as the support networks of survivors. IMPLICATIONS FOR CANCER SURVIVORS: A better and broader understanding of the effects of cognitive impairment both in the medical community and among lay people could pave the way for improved social and psychological services for this population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2017) · Qualitative Research Methods for Media Studies · doi:10.4324/9781315435978-2 · Cited by 1,483
Lorentzon, M. (1993) · Journal of Advanced Nursing · doi:10.1046/j.1365-2648.1993.180610057.x · Cited by 1,389
Crabtree, B. F., Miller, W. L., & Swenson, M. M. (1995) · Nursing Research · doi:10.1097/00006199-199507000-00011 · Cited by 956
van Dam, F. S. A. M., Boogerd, W., Schagen, S. B., Muller, M. J., Droogleever Fortuyn, M. E., Wall, E. V. D., & Rodenhuis, S. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.3.210 · Cited by 763
Ahles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., Whedon, M. B., Bivens, S., Mitchell, T., Greenberg, E. R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.485 · Cited by 736
Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma
Schagen, S. B., van Dam, F. S. A. M., Muller, M. J., Boogerd, W., Lindeboom, J., & Bruning, P. F. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990201)85:3<640::aid-cncr14>3.0.co;2-g · Cited by 620
Cognitive Function in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Brezden, C. B., Phillips, K.-A., Abdolell, M., Bunston, T., & Tannock, I. F. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.14.2695 · Cited by 557
Jenkins, V, Shilling, V, Deutsch, G., Bloomfield, D., Morris, R., Allan, S., Bishop, H., Hodson, N., Mitra, S., Sadler, G., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603029 · Cited by 407
Silverman, D. H. S., Dy, C. J., Castellon, S. A., Lai, J., Pio, B. S., Abraham, L., Waddell, K., Petersen, L., Phelps, M. E., & Ganz, P. A. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9380-z · Cited by 397
Neurocognitive Performance in Breast Cancer Survivors Exposed to Adjuvant Chemotherapy and Tamoxifen
Castellon, S. A., Ganz, P. A., Bower, J. E., Petersen, L., Abraham, L., & Greendale, G. A. (2004) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390490510905 · Cited by 396
‘Chemobrain’ in breast carcinoma?: A prologue
Wefel, J. S., Lenzi, R., Theriault, R., Buzdar, A. U., Cruickshank, S., & Meyers, C. A. (2004) · Cancer · doi:10.1002/cncr.20393 · Cited by 334
Cognitive impairment associated with adjuvant therapy in breast cancer
Bender, C. M., Sereika, S. M., Berga, S. L., Vogel, V. G., Brufsky, A. M., Paraska, K. K., & Ryan, C. M. (2006) · Psycho-Oncology · doi:10.1002/pon.964 · Cited by 320
Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer
Wieneke, M. H., & Dienst, E. R. (1995) · Psycho-Oncology · doi:10.1002/pon.2960040108 · Cited by 317
Falleti, M. G., Sanfilippo, A., Maruff, P., Weih, L., & Phillips, K.-A. (2005) · Brain and Cognition · doi:10.1016/j.bandc.2005.05.001 · Cited by 315
Hurria, A., Rosen, C., Hudis, C., Zuckerman, E., Panageas, K. S., Lachs, M. S., Witmer, M., Van Gorp, W. G., Fornier, M., D'Andrea, G., et al. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00732.x · Cited by 264
Shilling, V., Jenkins, V., Morris, R., Deutsch, G., & Bloomfield, D. (2005) · The Breast · doi:10.1016/j.breast.2004.10.004 · Cited by 208
Neurologic complications of chemotherapy agents
Kannarkat, G., Lasher, E. E., & Schiff, D. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3282f1a06e · Cited by 200
Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer
Shilling, V., & Jenkins, V. (2007) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2006.02.005 · Cited by 196
Tangpong, J., Cole, M. P., Sultana, R., Estus, S., Vore, M., St. Clair, W., Ratanachaiyavong, S., St. Clair, D. K., & Butterfield, D. A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04179.x · Cited by 185
Hurria, A., Somlo, G., & Ahles, T. A. (2007) · Cancer Investigation · doi:10.1080/07357900701506672 · Cited by 166
Downie, F. P., Fan, H. M., Tchen, N., Yi, Q., & Tannock, I. F. (2006) · Psycho-Oncology · doi:10.1002/pon.1035 · Cited by 142
Chemotherapy and cognitive deficits: Mechanisms, findings, and potential interventions
Nelson, C. J., Nandy, N., & Roth, A. J. L. (2007) · Palliative & Supportive Care · doi:10.1017/s1478951507000442 · Cited by 142
Donovan, K. A., Small, B. J., Andrykowski, M. A., Schmitt, F. A., Münster, P. N., & Jacobsen, P. B. (2005) · Cancer · doi:10.1002/cncr.21482 · Cited by 133
Cognitive Function and Reproductive Hormones in Adjuvant Therapy for Breast Cancer
Bender, C. M., Paraska, K. K., Sereika, S. M., Ryan, C. M., & Berga, S. L. (2001) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(01)00268-8 · Cited by 118
Matsuda, T., Takayama, T., Tashiro, M., Nakamura, Y., Ohashi, Y., & Shimozuma, K. (2005) · Breast Cancer · doi:10.2325/jbcs.12.279 · Cited by 101
Is 'chemo-fog'/'chemo-brain' caused by cancer chemotherapy?
Raffa, R. B., Duong, P. V., Finney, J., Garber, D., Lam, L. M., Mathew, S. S., Patel, N. N., Plaskett, K. C., Shah, M., & Weng, H.-F. J. (2006) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2006.00726.x · Cited by 79
Ganz, P. A. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.3.182 · Cited by 58
Chemo brain – A psychotropic drug phenomenon?
Jackson, G. E. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.06.019 · Cited by 20
Resources for Treatment of Chemotherapy‐Related Cognitive Difficulty
Grober, S. E. (2002) · Cancer Practice · doi:10.1046/j.1523-5394.2002.104005.x · Cited by 12
Cited by
Wefel, J. S., Kesler, S. R., Noll, K. R., & Schagen, S. B. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21258 · Cited by 532
Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review
Hutchinson, A. D., Hosking, J. R., Kichenadasse, G., Mattiske, J. K., & Wilson, C. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.05.002 · Cited by 464
Duijts, S. F. A., van Egmond, M. P., Spelten, E., van Muijen, P., Anema, J. R., & van der Beek, A. J. (2014) · Psycho-Oncology · doi:10.1002/pon.3467 · Cited by 356
Impaired Cognitive Function and Hippocampal Neurogenesis following Cancer Chemotherapy
Christie, L.-A., Acharya, M. M., Parihar, V. K., Nguyen, A., Martirosian, V., & Limoli, C. L. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2000 · Cited by 311
Cognitive Training for Improving Executive Function in Chemotherapy-Treated Breast Cancer Survivors
Kesler, S., Hadi Hosseini, S. M., Heckler, C., Janelsins, M., Palesh, O., Mustian, K., & Morrow, G. (2013) · Clinical Breast Cancer · doi:10.1016/j.clbc.2013.02.004 · Cited by 300
“Exclusion criteria included (1) previous chemotherapy treatment; (2) major sensory deficit (eg, blindness); (3) color blindness, because some of the training tasks and cognitive tests relied on color; (4) neurologic or major medical conditions known to affect cognitive function; (5) history of inpatient psychiatric ho…”
Background
Metadata
- Authors
- Boykoff, N., Moieni, M., & Subramanian, S. K.
- Venue
- Journal of Cancer Survivorship
- Published
- 2009-09-16
- Volume
- 3
- Issue
- 4
- Pages
- 223-32
- ISSN
- 1932-2259 (ISSN-L)
- 1932-2267
- OpenAlex
- W2130390212
- Cited by
- 519
- References
- 29
- FWCI
- 11.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.